170 related articles for article (PubMed ID: 6293990)
41. An electrophysiological and morphological study of the neuromuscular junction in patients with myasthenia gravis.
Albuquerque EX; Rash JE; Mayer RF; Satterfield JR
Exp Neurol; 1976 Jun; 51(3):536-63. PubMed ID: 179836
[No Abstract] [Full Text] [Related]
42. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
Kawanami S; Tsuji R; Oda K
Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
[TBL] [Abstract][Full Text] [Related]
43. Myasthenogenicity of a human acetylcholine receptor alpha-subunit peptide: morphology and immunology.
Matsuo H; Tsujihata M; Satoh A; Takeo G; Yoshimura T; Nagataki S
Muscle Nerve; 1992 Mar; 15(3):282-7. PubMed ID: 1372965
[TBL] [Abstract][Full Text] [Related]
44. Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane.
Corey AL; Richman DP; Agius MA; Wollmann RL
J Immunol; 1987 May; 138(10):3269-75. PubMed ID: 3494763
[TBL] [Abstract][Full Text] [Related]
45. Myasthenia gravis. Current concepts.
Gutmann L; Chou SM
Arch Pathol Lab Med; 1976 Aug; 100(8):401-4. PubMed ID: 947303
[TBL] [Abstract][Full Text] [Related]
46. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange.
Newsom-Davis J; Pinching AJ; Vincent A; Wilson SG
Neurology; 1978 Mar; 28(3):266-72. PubMed ID: 564482
[TBL] [Abstract][Full Text] [Related]
47. Antibodies to acetylcholine receptors as probes of receptor structure and pathological agents in myasthenia gravis.
Lindstrom J
Prog Clin Biol Res; 1981; 63():419-28. PubMed ID: 6171828
[No Abstract] [Full Text] [Related]
48. Idiotypes and anti-idiotypes of human autoantibodies to the acetylcholine receptor in myasthenia gravis.
Lefvert AK
Monogr Allergy; 1987; 22():57-70. PubMed ID: 3325836
[No Abstract] [Full Text] [Related]
49. Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis.
Tsujihata M; Yoshimura T; Satoh A; Kinoshita I; Matsuo H; Mori M; Nagataki S
Neurology; 1989 Oct; 39(10):1359-63. PubMed ID: 2797459
[TBL] [Abstract][Full Text] [Related]
50. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
Andreis I; Lovnićki TJ; Beara N; Taradi M
Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
[TBL] [Abstract][Full Text] [Related]
51. How to recognize an antibody-mediated autoimmune disease: criteria.
Drachman DB
Res Publ Assoc Res Nerv Ment Dis; 1990; 68():183-6. PubMed ID: 2183310
[No Abstract] [Full Text] [Related]
52. [Study of antibodies to motor end-plate in ocular myasthenia gravis].
Kinoshita I; Tsujihata M; Motomura M; Yoshimura T; Nagataki S
Rinsho Shinkeigaku; 1991 May; 31(5):500-4. PubMed ID: 1934762
[TBL] [Abstract][Full Text] [Related]
53. Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis.
Martínez-Martínez P; Losen M; Duimel H; Frederik P; Spaans F; Molenaar P; Vincent A; De Baets MH
Am J Pathol; 2007 Feb; 170(2):644-57. PubMed ID: 17255332
[TBL] [Abstract][Full Text] [Related]
54. The pathogenesis of myasthenia gravis.
Heilbronn E; Stålberg E
J Neurochem; 1978 Jul; 31(1):5-11. PubMed ID: 209148
[No Abstract] [Full Text] [Related]
55. Autoantibodies in myasthenia gravis: demonstration of anti-motor endplate antibody and anti-muscle membrane antibody using membrane immunofluorescence technique.
Arimori S; Tada S; Nakata Y; Kobashi H; Ichikawa Y
Acta Med Okayama; 1975 Dec; 29(6):397-404. PubMed ID: 132840
[TBL] [Abstract][Full Text] [Related]
56. Myasthenia gravis: demonstration of membrane attack complex in muscle end-plates.
Fazekas A; Komoly S; Bózsik B; Szobor A
Clin Neuropathol; 1986; 5(2):78-83. PubMed ID: 3519034
[TBL] [Abstract][Full Text] [Related]
57. Monoclonal anti-acetylcholine receptor antibodies with differing capacities to induce experimental autoimmune myasthenia gravis.
Gomez CM; Richman DP
J Immunol; 1985 Jul; 135(1):234-41. PubMed ID: 3873489
[TBL] [Abstract][Full Text] [Related]
58. [Myasthenia gravis (1). Experimental myasthenia gravis--a tool for the study of the pathogenesis, diagnosis and treatment of myasthenia gravis].
Heilbronn E
Lakartidningen; 1978 Oct; 75(41):3663-4, 3669. PubMed ID: 692231
[No Abstract] [Full Text] [Related]
59. Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton-Lambert syndrome.
Lindstrom JM; Lambert EH
Neurology; 1978 Feb; 28(2):130-8. PubMed ID: 202890
[No Abstract] [Full Text] [Related]
60. Myasthenia gravis.
Newsom-Davis J
Ann Ital Med Int; 1988; 3 Suppl 1():32-7. PubMed ID: 3152864
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
